This in-depth event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing and focused networking

Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development 

• Advancements and emerging trends in the application of technology in developing neurological treatments
• Neuroscience biomarker development
• Translational approaches for drug discovery
• Opportunities and challenges of designing and implementing targeted diagnostics and therapeutics
• Diagnostic tool development
• Digital Pathology, AI and Imaging strategies for Biomarker development

 
Track 2: Drug Discovery for Neurodegenerative Diseases 

• Target identification and validation approaches
• Stem cell technology to fuel drug discovery
• iPS cells for disease modelling and drug discovery
• Blood brain barrier in CNS drug discovery
• Assay Development & Screening
• In vitro and in vivo disease modelling
• The role of informatics in CNS drug discovery

This event is co-located with the Discovery Europe 2023

Attendees will have full access to both events.